We are live on
!
Find out more
Tonix Pharmaceuticals
TNXP
TNXP
hedge funds and large institutions have $48.9M invested in Tonix Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
345% more call options, than puts
Call options by funds: $984K | Put options by funds: $221K
27% less capital invested
Capital invested by funds: $66.7M → $48.9M (-$17.8M)
Holders
Holders Change
–
Holders Change %
–
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
$984K
Puts
$221K
Net Calls
+$763K
Net Calls Change
+$595K
Top Buyers
No buyers this quarter
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$1.15M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$225K |
| 3 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$164K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
-$115K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$33K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CS
51
Credit Suisse
Zurich,
Switzerland
| – | -$225K | – | – |
|
|
PAM
52
Panagora Asset Management
Boston,
Massachusetts
| – | -$33K | – | – |
|
|
53
Renaissance Technologies
New York
| – | -$1.15M | – | – |
|
|
TC
54
TFS Capital
West Chester,
Pennsylvania
| – | -$164K | – | – |
|
|
TRCT
55
Tower Research Capital (TRC)
New York
| – | -$3K | – | – |
|
|
VKH
56
Virtu KCG Holdings
New York
| – | -$115K | – | – |
|